Ian Brown

PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells

Tasuku Honjo, Yoshiko Iwai, T. Honjo, 2004, Cancer Research.

Immune resistance orchestrated by the tumor microenvironment

C. Blank, T. Gajewski, A. Kacha, 2006, Immunological reviews.

Absence of Programmed Death Receptor 1 Alters Thymic Development and Enhances Generation of CD4/CD8 Double-Negative TCR-Transgenic T Cells 1

Tasuku Honjo, T. Honjo, C. Blank, 2003, The Journal of Immunology.